Steven Bbuye, MD
Emergency Medicine · Brockton, MANPI 1780943506
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $161,723 of the $164,057 with a category attached, or 98.6%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Among emergency medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $2646.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$164K
- Novo Nordisk$14
What the payments were for
- Consulting fees$161,72399%
- Travel & lodging$1,8451%
- Food & beverage$140%
- Education$4750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 61 | $164,043 |
| Novo Nordisk | 1 | $14 |
How this compares
$164,057 in reported general payments places this provider in the 95th percentile of 1,429 emergency medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 19 | $21,134 |
| EliquisApixaban | 51 | $7,282 |
| JanuviaSitagliptin Phosphate | 33 | $5,114 |
| Permethrin | 46 | $2,011 |
| LantusInsulin Glargine,hum.Rec.Anlog | 21 | $1,978 |
| Divalproex Sodium | 73 | $1,067 |
| Mirtazapine | 93 | $854 |
| Trazodone Hcl | 205 | $820 |
| Gabapentin | 90 | $459 |
| Quetiapine Fumarate | 64 | $454 |
| Amlodipine Besylate | 88 | $446 |
| Risperidone | 80 | $444 |
| Sertraline Hcl | 83 | $436 |
| Memantine Hcl | 67 | $420 |
| Levothyroxine Sodium | 91 | $413 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Brockton
- Richard HermanBrockton$43K
- James ThomasBrockton$11K
- Sushama ScaleraSalem$4M
- Christopher GilliganBoston$1M
- Nathan ShapiroBoston$311K
- Joshua GoldsteinBoston$234K
- Adaira LandryBoston$211K
- Elissa PerkinsBoston$205K
- Christopher BaughBoston$146K
- Andrew GoldsmithBurlington$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.